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Sir,
We appreciate the interest of Drs Clement and Champ in
our article, which provided overall compelling evidence for
a negative impact of corticosteroid medication on survival
in patients with glioblastoma. Our colleagues raise the
interesting hypothesis that part of this adverse effect of
corticosteroids is through its elevation of blood glucose
levels. They reason that elevated glucose in turn may
induce resistance to radiotherapy and may overall facili-
tate survival of glioblastoma cells under untoward
microenvironmental conditions. While we do not necessar-
ily concur with the view that hyperglycaemia is the most
prominent side-effect of steroids in the context of glioblast-
oma, the hypothesis is nevertheless interesting and could be
tested with appropriate experimental models. The evidence
in the literature summarized by our colleagues further lends
support to our recommendation that steroid use in glio-
blastoma patients should be limited to the dose and dur-
ation considered absolutely necessary.
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